Background A number of papers have recently been published examining the magnitude of scale economies in neonatal care and the level of activity at which these become attainable. Although these agree there is scope for economies in the production of neonatal care, they debate the extent to which such economies are attainable and how they might best be detected. A major multicentre study of neonatal units in the United Kingdom has produced costing and activity data allowing these issues to be explored afresh.
Introduction
As health care budgets come under increasing pressure, efficiency becomes more important. Technical efficiency requires that the resources consumed in the production of a given output be minimized. In essence, this means that as much health care of a given type is produced from a given expenditure as is possible. Examining the relationship between output and the resources required to produce that output can help ensure such efficiency is attained. Such information is clearly of value to policy makers in planning the provision of care.
In the United Kingdom, the issue of costs and the relationship between average cost per day of care produced and the size of the neonatal unit has received much attention. [1] [2] [3] [4] [5] A number of papers have recently been published examining the magnitude of scale economies and the level of activity at which these become attainable. 4, 5 Although there appears to be a consensus that there is scope for economies in the production of neonatal care, there is less agreement on the extent to which such economies are attainable and how they might best be detected. [6] [7] [8] As the debate is based upon analyses of a single dataset containing only 17 observations, 4 it is unlikely to be resolved without further data. The interest implicit in these papers, nevertheless, underscores the importance of efficiency in neonatal care.
A major multicentre study of neonatal units in the United Kingdom has produced costing and activity data allowing these issues to be explored afresh. The new data have the advantage both of being more recent and of covering more observations than previous studies, thus affording the opportunity to explore the issue of scale economies more rigorously than has hitherto been possible.
Method

The data
A multidisciplinary study group composed of clinicians, economists and research nurses was formed in 1991. The group covered a range of disciplines necessary to a study of the economic issues of surfactant therapy. A sample of 57 neonatal units was chosen from geographical regions in the United Kingdom within access of the research team to determine the relationship between unit size, case-mix and cost. These units covered those participating in continuing studies of surfactanta drug used in neonatal care (the OSIRIS 9 and Curosurf 4 10 studies). The sample included all units in Scotland, Northern Ireland, and the former Northern, South East Thames and Oxford Regions. A small number of other units geographically close to these regions were also included in the study. The sample represents approximately 20 per cent of all units operating in the United Kingdom at that time. Units in the sample varied in size from those providing less than 2000 days of care per annum to those providing in excess of 10 000 days, as well as teaching and non-teaching hospitals.
To control for the possibility of different units using different classifications of care (i.e. defining activity differently), a 5 per cent random sample of admissions to the units in the sample was drawn for the period 1990-1991. Patient data for the 10 354 days of care this constituted were recorded by research nurses who visited the units. An analysis of these records revealed that units varied in terms of how they defined activity at different levels of care. 11 These retrospective comparisons between neonatal units using different classifications of care could only reliably differentiate between two levels of care: receiving respiratory support and other. Intensive care days were therefore defined as days when respiratory support was given. 'Other days' was defined as all days in the neonatal unit not classified as intensive. 11 Defining the amount of intensive care more precisely, for example, in terms of hours of care provided rather than days, was not considered practicable. Clinicians within the team confirmed that no units routinely collected information of such precision. Casemix was defined as the proportion of intensive care days to all care days provided. The total number of care days provided (intensive plus other) by each of the 57 units in the study, together with the number of intensive care days was collected by research nurses visiting the units. These data related to the financial year 1990-1991.
Data relating to costs of the financial year 1990-1991 of four types (medical staff, nursing staff, support and overheads) were requested from the units by means of a postal questionnaire circulated in 1991. Medical costs were defined as total salary costs by grade (including superannuation) plus bonuses, for staff in post during the study period. Details of these were provided by the consultant responsible for the unit and agreed with the hospital finance department. Nursing costs were similarly defined -being total staffing costs by grade (including superannuation) for staff in post. Details of these were provided by the nurse manager responsible for the unit and again agreed with the finance department. Where staff time was shared between the unit and other duties, costs were apportioned to the unit based on time spent there.
Support costs covered such consumables as drugs, dressings and pathology completed outside the unit or by staff not employed by it. Details of these were completed by nursing and medical staff at the unit. Finally, overhead costs covered such items as portering, administrative support (e.g. secretaries), cleaning, heat, light and power consumed by the unit. Often these items were apportioned by floor area by the hospital finance department (with assistance from medical and nursing staff). Although overheads and support costs are likely to be less accurately estimated than staffing costs there is no reason to assume that their estimation is biased, i.e. that relative errors in their estimation vary systematically between units of different size or with different case-mixes.
At the time of the study, it was not National Health Service practice to include capital costs in hospital cost estimates. Overhead costs therefore exclude the capital value of buildings. A further element of capital cost, equipment, was also excluded from our cost function, after a largely unsuccessful attempt to collect it. Relatively few units were able to supply such data and concerns were voiced by clinicians in the study group about the accuracy of those data that were forthcoming for some of the units. During the course of the study units were receiving surfactant at no charge from pharmaceutical firms, which would also lead estimated total costs to underestimate those actually incurred. It follows that exclusion of these elements of cost implies that absolute costs as calculated here will underestimate those incurred in practice. Moreover, in relation to equipment, exclusion could introduce some distortion into the estimated relationship between cost and activity. Relatively large units may be able to gain economies of scale with respect to such equipment, for instance, in maintenance arrangements. Thus, the difference in average costs between relatively large and small units may be greater than estimated.
For 18 units, what were considered by the team to be reliable data relating to equipment costs were returned. For these units (which were representative of a cross-section of those in the study), equipment costs, calculated on an annual equivalent basis, were estimated to average just 4.3 per cent of total costs (ranging from 7.2 to 2.9 per cent among individual units). Given their contribution to total costs in these units, it is considered that the effect of exclusion of equipment costs from the cost function was small. For other cost elements, e.g. drugs, likely to vary proportionately with activity, such problems should not arise, i.e. similar economies are unlikely to exist here.
The model
Production theory and the results of previous studies 4, 5 suggest that there are economies of scale in the provision of neonatal care. That is, the cost per day of care provided decreases with the size of the unit in terms of days of care it provides. On the same grounds, there is reason to believe that costs may depend on the case-mix in each unit, i.e. the proportion of intensive care 110 JOURNAL OF PUBLIC HEALTH MEDICINE days. 4, 5 A function in which both these variables appear as regressors was, therefore, considered appropriate. O'Neill and Largey 5 have argued that, in addition to their independent effects, there may be a combined or interaction effect of these variables upon costs. This means that a unit providing a large number of days in total may be able to use its mix of skills and expertise to produce intensive care relatively more cheaply than smaller ones, ceteris paribus. The number of intensive care days is positively correlated with the number of total days produced but unless this additional independent effect is captured, through use of an interaction effect, the model may be mis-specified.
In the light of these arguments, a function where costs were dependent upon total days of care, the proportion of intensive care days and an interaction effect between these two variables was investigated. To determine the relative fits of models to the data, costs were specified in terms of both average cost per day and total costs in the analyses. For comparative purposes a regression model of the form estimated by Fordham et al. 4 was also used. The estimation of each model was accompanied by a Box Cox regression 12 to ascertain the appropriateness of the functional form used.
The incorporation of additional explanatory variables into the analysis, such as, for example, the birth weight or illness severity of babies treated by units, or the admission policies of units related to this variable was not attempted. How such variables could be incorporated into the model -especially given only 57 units would be studied -was not obvious. The role of such variables may be worth exploring in future work.
Results
Of the 57 units agreeing to participate in the study and supplying details of care provided, 49 were able to supply details of medical, nursing, overhead and support costs. Data and summary statistics relating to these are contained in Tables  1 and 2. In Table 3 a correlation matrix between the various elements of cost and total cost together with level of activity is shown. The high correlation between the variables included in the cost functions indicates multi-collinearity in the regression models, which will reduce the significance of each variable. This is inevitable with data of this type and does not lead to a bias in the estimated coefficients. It does, however, make us cautious in our interpretation of the likely relationship between variables. In Table 4 the results of the regressions for the various models are shown, and in Table 5 the results of the Box Cox regressions for Models 1 and 2 are given.
For Model 1 (where total costs are the dependent variable) the Box Cox regression results support the use of a double-log functional form. The better overall fit for this model (R 2 = 0.71) and the greater significance of individual regressors compared with those of other models demonstrate that this functional form best describes the cost function relationship in this case. To ascertain if the results of the Box Cox model were sensitive to the starting values suggested for the appropriate functional form, a grid search 12 for v and l (the power to which left-and right-hand-side variables are raised) in the range ¹1 to þ1 was conducted. The results of the Box Cox regression remained robust over this range, suggesting a double-log form was indeed appropriate. (Model 3 is equivalent to Model 1, case-mix being defined in one in terms of the percentage of intensive care days and in the other in terms of the proportion of intensive care days. Given the two models are in essence the same, no further discussion of Model 3 is presented here; it is shown merely for completeness.) Model 2 is similar to that estimated by Fordham et al. 4 in the first study of this type conducted in the United Kingdom. The Box Cox regression was initiated around a quadratic model like that used in their study. The results suggest that this does not provide a suitable fit to the data. (The non-significance of the transformations to the left-and right-hand-side variables suggests that a double-log functional form would be more appropriate.) This, with the regression results themselves (Table 4) , which show this model provides a poor fit, is sufficient to reject this functional form for describing the cost relationship.
Model 4 -argued by O'Neill and Largey 5 to provide a superior fit to the data of Fordham et al. 4 than the Fordham et al. model 4 -is seen not to perform as well for these data as Model 1. It, therefore, is also rejected. Table 6 shows estimates of the average cost per day of care at a range of scales and case-mixes. The model also supports the policy of promptly transferring infants who no longer require intensive care from larger referral units to smaller units. For example, average costs per day are £231-£297 in units with an annual volume of 8000-9000 days and a proportion of 0.2-0.4 intensive care days or less, compared with £189-£229 in units with an annual volume of 3000-4000 days and a proportion of 0.02 intensive care days or less. That smaller units may be more accessible to parents could bring further benefits from such a policy.
Discussion
The regression results suggest that the relationship between 112 JOURNAL OF PUBLIC HEALTH MEDICINE costs and activity (as defined here) may be appropriately defined by a double-log function containing among its explanatory variables an interaction effect between total days and the proportion of intensive care days. This is not to say that for other datasets, notably those including data on capital costs, other functional forms may prove more appropriate to that used here.
It is noticeable that scale effects (as measured by the percentage fall in costs as total days increase) are more marked among units providing relatively little intensive care than among those providing a high proportion of care of this type (see, for example, the figures quoted in Table 6 ). This result is consistent with expectations. Thus, in as much as the production of intensive care days offers less opportunity for substitution within types of labour (relatively less qualified for relatively more qualified staff) or savings in staff time generally -it is almost by definition more labour intensive -the opportunity to effect cost savings will be less.
It is clear that scale economies can be demonstrated in neonatal unit daily costs. This is consistent with previous studies in two UK populations, which demonstrated that the provision of intensive care in small neonatal units would substantially increase the total number of cots required to meet the demand for neonatal intensive care. 13, 14 However, some care is needed before this study can be used to inform policy on provision of neonatal care. It must be remembered that capital costs were excluded from our analysis and in consequence the nature of scale economies may be underestimated (i.e. had we included these, scale economies may have been even greater). Moreover, no direct inference can be made from any of this or previous studies as to how cost-effectiveness and not just costs varies with scale.
What are the implications for policy and research? If we assume that outcomes from neonatal care are equally good at every observed combination of patient volume and case-mix and that allocations of resources between non-intensive and intensive care within and between units are consistent and appropriate, then the least costly solution might also be the most cost-effective. However, further evidence about the relationship between scale of activity and outcomes of neonatal care is needed.
Several studies in the United Kingdom [15] [16] [17] [18] and elsewhere [19] [20] [21] [22] [23] [24] [25] [26] have reported increased mortality for high-risk infants born in smaller or non-tertiary hospitals with fewer resources for neonatal intensive care. A study of nine Scottish neonatal units 27 found in a secondary analysis that the largest unit had the lowest risk adjusted mortality. A more recent study in Trent suggested that after increased investment in the smallest units, their risk adjusted mortality was no longer greater than that of larger units. 28 The interpretation of these studies, however, is complicated by a wide range of confounding factors, including variations in definitions of activity, [29] [30] [31] social disadvantage, clinical risk and illness severity, 31 staff numbers, skill and incomplete uptake of The insignificance of l and v suggests that the appropriate transformations for left-and right-hand-side variables is a log form. All variables are defined as in Table 4 .
effective therapies. 31 The UK Neonatal Staffing Study 32 will address several of these issues in relation to costs and risk adjusted outcome.
If it were to confirm that outcomes were better in neonatal units with greater activity, community perceptions would need to be changed so that best care was recognized to be preferable to nearby care. If, on the other hand, no relationship were established between scale of activity and outcome, other aspects of equity, such as ease of access, would become more important. Thus, it might not always be appropriate to deliver care at the level predicted in our model to be the least costly, if this reduced access to people living far away from large centres.
Finally, our predictive model and the cost data from which it is derived may be useful in other UK costing studies of neonatal care, although given the caveats raised it is recognized that care is warranted in its use. The data have proved useful in a recent economic evaluation and randomized controlled trial of extracorporeal membrane oxygenation. 33 
